INS and cancer: The results suggested that the protective effect of metformin on thyroid cancer was not restricted to a certain group of age or sex; and was not affected by excluding users of insulin, sulfonylurea, and insulin/and or sulfonylurea, respectively, by previous diagnosis of other cancers or by potential detection examinations.